Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 276INDUSTRY 66NIH 18OTHER_GOV 9NETWORK 6FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 7Uterine Cervical Neoplasms 4Endometrial Neoplasms 3Breast Neoplasms 3Colorectal Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Stroke 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Leiomyoma 1Genital Neoplasms, Female 1Diabetes Mellitus 1Diabetes Insipidus 1Depression, Postpartum 1Coronary Disease 1Breast Neoplasms, Male 1Breast Feeding 1

Interventions

Imiquimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Uterine Cervical Dysplasia × Gynecologic × Clear all
NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed
22 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡